Farley J. Abad

Array ( [id] => 7250067 [patent_doc_number] => 20050272645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Retrocyclins: antiviral and antimicrobial peptides' [patent_app_type] => utility [patent_app_number] => 10/982145 [patent_app_country] => US [patent_app_date] => 2004-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 18752 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272645.pdf [firstpage_image] =>[orig_patent_app_number] => 10982145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7007078 [patent_doc_number] => 20050172343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Astrocyte modulated genes and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/975280 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17347 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20050172343.pdf [firstpage_image] =>[orig_patent_app_number] => 10975280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7161626 [patent_doc_number] => 20050084947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-21 [patent_title] => 'Recombinant RSV virus expression systems and vaccines' [patent_app_type] => utility [patent_app_number] => 10/975060 [patent_app_country] => US [patent_app_date] => 2004-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 34817 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20050084947.pdf [firstpage_image] =>[orig_patent_app_number] => 10975060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7103457 [patent_doc_number] => 20050106183 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Method of treating pain' [patent_app_type] => utility [patent_app_number] => 10/967501 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3727 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20050106183.pdf [firstpage_image] =>[orig_patent_app_number] => 10967501 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5015738 [patent_doc_number] => 20070258946 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Combination Therapy for Treating Hepatitis C Virus Infection' [patent_app_type] => utility [patent_app_number] => 10/584169 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67947 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20070258946.pdf [firstpage_image] =>[orig_patent_app_number] => 10584169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 424838 [patent_doc_number] => 07270820 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'CD4+ T-lymphocyte-specific hepatitis C virus epitopes' [patent_app_type] => utility [patent_app_number] => 10/962145 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4429 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270820.pdf [firstpage_image] =>[orig_patent_app_number] => 10962145 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 478189 [patent_doc_number] => 07223595 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Use of purified Streptomyces griseus trypsin for production of a biomass of cells and viral propagation' [patent_app_type] => utility [patent_app_number] => 10/944218 [patent_app_country] => US [patent_app_date] => 2004-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9347 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223595.pdf [firstpage_image] =>[orig_patent_app_number] => 10944218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7110613 [patent_doc_number] => 20050208068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Malaria immunogen and vaccine' [patent_app_type] => utility [patent_app_number] => 10/930696 [patent_app_country] => US [patent_app_date] => 2004-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 31064 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20050208068.pdf [firstpage_image] =>[orig_patent_app_number] => 10930696 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740531 [patent_doc_number] => 20080234184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Vectors For the Co-Expression of Membrane Domains of Viral Envelope Proteins and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 10/569882 [patent_app_country] => US [patent_app_date] => 2004-08-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12186 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234184.pdf [firstpage_image] =>[orig_patent_app_number] => 10569882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250672 [patent_doc_number] => 07582428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Methods and compositions for identifying anti-HCV agents' [patent_app_type] => utility [patent_app_number] => 10/528377 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 17 [patent_no_of_words] => 17093 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582428.pdf [firstpage_image] =>[orig_patent_app_number] => 10528377 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 424830 [patent_doc_number] => 07270812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-09-18 [patent_title] => 'Pharmaceutical composition for treatment of cancers' [patent_app_type] => utility [patent_app_number] => 10/911580 [patent_app_country] => US [patent_app_date] => 2004-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 6835 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/270/07270812.pdf [firstpage_image] =>[orig_patent_app_number] => 10911580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004510 [patent_doc_number] => 20070202078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Method Of Treating Viral Infections' [patent_app_type] => utility [patent_app_number] => 10/568176 [patent_app_country] => US [patent_app_date] => 2004-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4752 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202078.pdf [firstpage_image] =>[orig_patent_app_number] => 10568176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479189 [patent_doc_number] => 07223840 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-29 [patent_title] => 'Antimicrobial peptide' [patent_app_type] => utility [patent_app_number] => 10/902853 [patent_app_country] => US [patent_app_date] => 2004-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15833 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223840.pdf [firstpage_image] =>[orig_patent_app_number] => 10902853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328032 [patent_doc_number] => 20040253578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Dynamic action reference tools' [patent_app_type] => new [patent_app_number] => 10/474298 [patent_app_country] => US [patent_app_date] => 2004-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 69311 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253578.pdf [firstpage_image] =>[orig_patent_app_number] => 10474298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7010811 [patent_doc_number] => 20050064527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'NIMR compositions and their methods of use' [patent_app_type] => utility [patent_app_number] => 10/893671 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39082 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20050064527.pdf [firstpage_image] =>[orig_patent_app_number] => 10893671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5661027 [patent_doc_number] => 20060251623 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Packaged virus-like particles' [patent_app_type] => utility [patent_app_number] => 10/563944 [patent_app_country] => US [patent_app_date] => 2004-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22803 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20060251623.pdf [firstpage_image] =>[orig_patent_app_number] => 10563944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 232646 [patent_doc_number] => 07598071 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-10-06 [patent_title] => 'Infectious clone of human parvovirus B19 and methods' [patent_app_type] => utility [patent_app_number] => 10/887770 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 31 [patent_no_of_words] => 21183 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/598/07598071.pdf [firstpage_image] =>[orig_patent_app_number] => 10887770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050901 [patent_doc_number] => 20070031446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Hcv vaccines' [patent_app_type] => utility [patent_app_number] => 10/564429 [patent_app_country] => US [patent_app_date] => 2004-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13130 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031446.pdf [firstpage_image] =>[orig_patent_app_number] => 10564429 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082699 [patent_doc_number] => 20050048079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'In vivo CTL elicitation by heat shock protein fusion proteins maps to a discrete domain and is CD4+ T cell-independent' [patent_app_type] => utility [patent_app_number] => 10/885523 [patent_app_country] => US [patent_app_date] => 2004-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13643 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048079.pdf [firstpage_image] =>[orig_patent_app_number] => 10885523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7328614 [patent_doc_number] => 20040253695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Novel enone reductases, methods for producing same, and methods for selectively reducing a carbon-carbon double bond of an alpha, beta-unsaturated ketone using the reductases' [patent_app_type] => new [patent_app_number] => 10/879250 [patent_app_country] => US [patent_app_date] => 2004-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13838 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253695.pdf [firstpage_image] =>[orig_patent_app_number] => 10879250 [rel_patent_id] =>[rel_patent_doc_number] =>)